In vivo model design and assay selection to aid in progression from preclinical to clinical

Presented by Isabelle Meunier during World Vaccine Congress 2023

Vaccine development is a complex path with multiple checkpoints and steps. In this presentation, we discuss the critical factors that must be assessed in the preclinical stage including: animal models, preclinical endpoints, assay selection and development and the transition to the clinical phase. By focusing on the pros/cons of the available choices, this presentation can help you to ease the overall complexity of the vaccine development process.


Complete the form below to access the presentation.